| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $252,224,520 ) (Continued on the next page) |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | F32DK137454 | Examining the role of epigenetic memory in intestinal regeneration | 000 | 1 | NIH | 1/30/2024 | $69,500 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | R01EY035028 | Retinal mechanisms underlying the optokinetic reflex | 000 | 1 | NIH | 12/29/2023 | $463,720 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | F99HG013437 | Assessing Clinical Utility of Polygenic Risk Scores in Ancestrally Diverse Real-World Cohorts | 003 | 1 | NIH | 1/31/2024 | $0 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | F31HL172581 | Systems genomics approach to targeting glucose toxicity during pathological cardiomyocyte hypoxia | 001 | 1 | NIH | 12/8/2023 | $0 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | F99HG013437 | Assessing Clinical Utility of Polygenic Risk Scores in Ancestrally Diverse Real-World Cohorts | 001 | 1 | NIH | 1/18/2024 | $42,794 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | F99HG013437 | Assessing Clinical Utility of Polygenic Risk Scores in Ancestrally Diverse Real-World Cohorts | 001 | 1 | NIH | 1/18/2024 | -$42,794 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | F31HL172581 | Systems genomics approach to targeting glucose toxicity during pathological cardiomyocyte hypoxia | 000 | 1 | NIH | 12/8/2023 | $47,694 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | F99HG013437 | Assessing Clinical Utility of Polygenic Risk Scores in Ancestrally Diverse Real-World Cohorts | 002 | 1 | NIH | 1/22/2024 | $0 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | F99HG013437 | Assessing Clinical Utility of Polygenic Risk Scores in Ancestrally Diverse Real-World Cohorts | 000 | 1 | NIH | 12/20/2023 | $42,794 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | R01CA280071 | Translating Hyperpolarized 13C MRI as a Novel Tool to Predict Treatment Response in Pancreatic Cancer | 000 | 1 | NIH | 12/20/2023 | $670,223 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | R01EY035514 | Triple threat therapeutics for inherited retinal degenerations | 000 | 1 | NIH | 1/2/2024 | $452,724 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R21CA289565 | Synthetic combination therapy for diffuse midline gliomas | 000 | 1 | NIH | 2/23/2024 | $226,504 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | R01DK132129 | Modeling and Characterization of NAFLD Phenotypes in a Severely Affected Family | 000 | 1 | NIH | 1/29/2024 | $669,949 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | F31HL172610 | Adapting cell-based therapies for the treatment of pulmonary fibrosis | 001 | 1 | NIH | 12/1/2023 | $0 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R01AA031445 | A randomized controlled trial of an economic and relationship-strengthening intervention to reduce alcohol use in Malawi | 000 | 1 | NIH | 3/14/2024 | $723,551 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | K08HL169915 | SREBP1 as a Novel Mammalian Oxygen Sensor | 000 | 1 | NIH | 3/27/2024 | $162,972 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R33MD018333 | Group-based Integrative Pain Management: A multi-level approach to address intersectional stigma and social isolation in diverse primary care safety net patients with chronic pain | 000 | 2 | NIH | 4/25/2024 | $3,752,243 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | R01CA279328 | Maximizing tumor responses to targeted radiotherapy with a conditionally activated membrane binding probe | 000 | 1 | NIH | 12/22/2023 | $616,174 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R01DK136031 | Orexigenic AgRP neurons in the brainstem | 000 | 1 | NIH | 3/1/2024 | $478,058 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | P30HS029738 | Learning Health System Embedded Scientist Training and Research Center | 002 | 1 | AHRQ | 3/4/2024 | $0 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | P30HS029738 | Learning Health System Embedded Scientist Training and Research Center | 001 | 1 | AHRQ | 1/5/2024 | $0 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | K23HL172699 | Low Cardiorespiratory Fitness and Chronotropic Incompetence inHIV: Risk Factors, Cardiovascular Implications, and Exercise Training as Treatment | 000 | 1 | NIH | 2/29/2024 | $197,748 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | P30HS029738 | Learning Health System Embedded Scientist Training and Research Center | 000 | 1 | AHRQ | 12/27/2023 | $1,000,000 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | K23DA058044 | Ecological mHealth Cannabis Prevention for Youth Involved in the Juvenile Legal System | 000 | 1 | NIH | 4/1/2024 | $189,156 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | K23AR082960 | Addressing Cross-Cultural Adaptation of Patient Reported Outcome Measures for Distal Radius Fractures | 000 | 1 | NIH | 4/1/2024 | $168,212 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R01EY036139 | Roles of CaSR in ocular surface health and disease | 000 | 1 | NIH | 4/25/2024 | $396,242 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | S10OD036282 | High content screening system - Perkin Elmer Opera Phenix Plus | 000 | 1 | NIH | 2/29/2024 | $1,248,729 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R01CA281984 | Brain-Restricted Kinase Inhibition with Binary Pharmacology | 000 | 1 | NIH | 3/1/2024 | $671,177 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | F32MH136662 | Mapping the functional GPCR-ome and its signaling consequences in neurons | 002 | 1 | NIH | 3/6/2024 | $0 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | F32MH136662 | Mapping the functional GPCR-ome and its signaling consequences in neurons | 000 | 1 | NIH | 3/1/2024 | $74,080 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | R01NS126499 | Generation and analysis of mouse models to define the roles of the ALS-associated factor Zfp106/ZNF106 in neurodegeneration | 000 | 1 | NIH | 12/27/2023 | $420,917 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | F32MH136662 | Mapping the functional GPCR-ome and its signaling consequences in neurons | 001 | 1 | NIH | 3/6/2024 | $74,080 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | F32MH136662 | Mapping the functional GPCR-ome and its signaling consequences in neurons | 001 | 1 | NIH | 3/6/2024 | -$74,080 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | F31HL172606 | Elucidating the role of Scribble in angiogenic symmetry breaking and adherens junction remodeling | 001 | 1 | NIH | 12/27/2023 | $0 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | F31HL172606 | Elucidating the role of Scribble in angiogenic symmetry breaking and adherens junction remodeling | 000 | 1 | NIH | 12/27/2023 | $39,801 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R18HS029432 | Disseminating PCOR findings to Reduce Racial Disparities in Surgical Sterilization | 000 | 2 | AHRQ | 3/11/2024 | $499,999 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R01CA283826 | Bioengineering adipocytes for cancer therapy | 000 | 1 | NIH | 3/13/2024 | $643,221 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R21NS133533 | A critical role for microglial cholesterol 25-hydroxylase in regulating neuroinflammation following neonatal brain hypoxia-ischemia | 000 | 1 | NIH | 4/4/2024 | $204,219 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG3NS130527 | A fully implantable speech neuroprosthesis | 001 | 1 | NIH | 2/7/2024 | $0 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | UG3NS130527 | A fully implantable speech neuroprosthesis | 000 | 1 | NIH | 2/1/2024 | $1,526,494 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R01CA289874 | Develop novel bispecific antibody-drug conjugates against metastatic lethal prostate cancer across subtype | 000 | 1 | NIH | 3/28/2024 | $553,090 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG3NS130527 | A fully implantable speech neuroprosthesis | 002 | 1 | NIH | 2/23/2024 | $0 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | R61CA278518 | Quantitative analysis and manipulation of chromosome dynamics in cancer organoids | 000 | 1 | NIH | 2/1/2024 | $226,505 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94143-4249 | SAN FRANCISCO | USA | R01CA279997 | Targeting Oncogenic PKA signaling mechanisms | 000 | 1 | NIH | 12/15/2023 | $616,676 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | F31HL170757 | Uncovering the function of emerin and its regulation by secretory trafficking in human cardiomyocytes | 001 | 1 | NIH | 4/8/2024 | $0 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | F31HL170757 | Uncovering the function of emerin and its regulation by secretory trafficking in human cardiomyocytes | 000 | 1 | NIH | 4/8/2024 | $40,213 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | F31HD115372 | Effects of state-level initiatives to reduce early-term elective deliveries on maternal and newborn outcomes | 000 | 1 | NIH | 4/8/2024 | $50,194 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | F31CA291047 | Defining the Mechanistic Impact of PRC1 Overexpression on Mammalian Spindle Mechanics | 000 | 1 | NIH | 4/9/2024 | $40,213 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UH3NS128297 | Cerebellar deep brain stimulation for severe combined movement disorders and spasticity in children and young adults with cerebral palsy | 000 | 1 | NIH | 3/13/2024 | $1,131,043 |
|